<p>Genor Biopharma Holdings Ltd. provided an update regarding its merger, stating that upon completion of the transaction, the company will meet the necessary requirements for an adjustment to its stock short name. As a result, the “B” marker will be removed from both its English and Chinese stock short names, changing them from “GENOR-B” to “GENOR” and from “嘉和生物-B” to “嘉和生物” respectively, effective the business day immediately after the expected merger closing date on 30 December 2025. The company’s stock code “6998” will remain unchanged, and existing share certificates will continue to be valid for all purposes. Further announcements concerning the effective date of the new stock short name will be made in due course. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genor Biopharma Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251222-11963267), on December 22, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

06998

<p>Genor Biopharma to Drop "B" Marker After Merger Completion</p>